NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/31/2024
Back to search
Official data from USPTO
HIKMA 503B
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
HIKMA 503B
ST13
US500000090795613Class
5, 16, 44
Filing
90795613
Registration
7634125
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
12/31/2024
Trademark type
Word
Nice classes
5, 16, 44
Filing date
06/25/2021
Registration date
12/31/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/31/2024
Last transaction
12/31/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2021-06-00
First use in commerce
2021-12-00
Drawing code
4
Owner type
03
Owner location
Berkeley Heights, NJ, US
Examiner
FAIRBANKS, RONALD L
Law office
N10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Hikma Injectables USA Inc.
Representatives
Michelle E. Tochtrop PEARNE & GORDON LLP
Technical classification
Nice Classes
Class 5Class 16Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and medicinal preparations and substancessystemic anti-infectivespharmaceutical and medicinal substances for the preventioncuringtreatment of viralmetabolicalimentaryendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalparasiticpsychiatricimmune system related diseases and disorders; pharmaceutical and medicinal substances for the preventioncuringtreatment of allergiesinflammationpaininfectious diseasesblood diseases and disordersnervous system diseases and disordersmalignant neoplastic diseases and disordersimmunomodulating agent diseases and disorders; chemical preparations for pharmaceutical or medical purposesfor viralmetabolicalimentaryendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalparasiticpsychiatricimmune system related diseases and disordersallergiesinflammationpaininfectious diseasesblood diseases and disordersnervous system diseases and disordersmalignant neoplastic diseases and disordersimmunomodulating agent diseases and disorders
Class 16
Papercardboard; articles of paper or cardboardbagsenvelopespaper packaging materialspacking paperpacking cardboardnotebooksnotepadsfoldersbookmarkerscalendarsboxescoastersstationery paperpostersposter boardpaper stationery; printed matterprinted booksbookletsjournalsmagazinesnewspapersperiodicalspamphletsbrochuresmanualsleafletsinformational flyersinformational sheetsnewslettersinstructional worksheets all in the fields of medicinemedical technologypharmaceuticalshealthcare; printed instructional and teaching materialsprinted booksbookletsjournalsmagazinesnewspapersperiodicalspamphletsbrochuresmanualsleafletsinformational flyersinformational postersinformational sheetsnewslettersinstructional worksheets all in the fields of medicinemedical technologypharmaceuticalshealthcare; stationery; adhesive materialsadhesives for stationery or household purposesadhesive stickersadhesive notepads
Class 44
Pharmaceutical compounding services; medical testing and analysis for diagnostic or treatment purposes; genetic testing for medical purposes; advisory services relating to healthcare being medical diagnostic and treatment advisory services relating to health
Publications
History of USPTO decisions and trademark events.
35 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/31/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/27/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/27/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
10/27/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/27/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
10/27/2024
SNEA
SU-EXAMINER'S AMENDMENT WRITTEN
10/27/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
07/03/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
07/03/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/08/2024
GNRT
NON-FINAL ACTION E-MAILED
04/08/2024
CNRT
SU - NON-FINAL ACTION - WRITTEN
04/08/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/09/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/09/2024
IUAF
USE AMENDMENT FILED
12/20/2023
EISU
TEAS STATEMENT OF USE RECEIVED
12/20/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/28/2023
EX1G
SOU EXTENSION 1 GRANTED
06/26/2023
EXT1
SOU EXTENSION 1 FILED
06/26/2023
EEXT
SOU TEAS EXTENSION RECEIVED
06/26/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/27/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/01/2022
PUBO
PUBLISHED FOR OPPOSITION
11/01/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/12/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/26/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/21/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/20/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/20/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/24/2022
GNRT
NON-FINAL ACTION E-MAILED
03/24/2022
CNRT
NON-FINAL ACTION WRITTEN
03/24/2022
DOCK
ASSIGNED TO EXAMINER
03/16/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/09/2021
NWAP
NEW APPLICATION ENTERED
06/29/2021
Continuous trademark protection
Get notified about every new filing that threatens HIKMA 503B or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.